Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Dosages and Cost-Benefit Comparisons of Drug Therapy

Dosages and Cost-Benefit Comparisons of Drug Therapy This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract In the article entitled "Cost-Benefit Issues in the Practice of Internal Medicine" that appeared in the June 1991 issue of the Archives (1991;151:1165-1168), the nadolol dose on page 1166, column 1, lines 32-36, is listed as 40 mg three times daily. The sentence should have read as follows: "Among the most commonly used β-blocking agents, based on most recent wholesale prices, a 1-week course of nadolol (40 mg/d) and atenolol (50 mg/d) are approximately equivalent in cost and remain at least six times as expensive as propanolol hydrochloride (40 mg three times a day)." http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Internal Medicine American Medical Association

Dosages and Cost-Benefit Comparisons of Drug Therapy

Archives of Internal Medicine , Volume 151 (11) – Nov 1, 1991

Dosages and Cost-Benefit Comparisons of Drug Therapy

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract In the article entitled "Cost-Benefit Issues in the Practice of Internal Medicine" that appeared in the June 1991 issue of the Archives (1991;151:1165-1168), the nadolol dose on page 1166, column 1, lines 32-36, is listed as 40 mg three times daily. The sentence should have read as follows: "Among the most commonly used β-blocking...
Loading next page...
 
/lp/american-medical-association/dosages-and-cost-benefit-comparisons-of-drug-therapy-DJcPhF80yl
Publisher
American Medical Association
Copyright
Copyright © 1991 American Medical Association. All Rights Reserved.
ISSN
0003-9926
eISSN
1538-3679
DOI
10.1001/archinte.1991.00400110078016
Publisher site
See Article on Publisher Site

Abstract

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables. Abstract In the article entitled "Cost-Benefit Issues in the Practice of Internal Medicine" that appeared in the June 1991 issue of the Archives (1991;151:1165-1168), the nadolol dose on page 1166, column 1, lines 32-36, is listed as 40 mg three times daily. The sentence should have read as follows: "Among the most commonly used β-blocking agents, based on most recent wholesale prices, a 1-week course of nadolol (40 mg/d) and atenolol (50 mg/d) are approximately equivalent in cost and remain at least six times as expensive as propanolol hydrochloride (40 mg three times a day)."

Journal

Archives of Internal MedicineAmerican Medical Association

Published: Nov 1, 1991

There are no references for this article.